- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 13, 2026 | 1.25M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 1.06M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 4.05K sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$7.97M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$6.58M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $14.53M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $21.62M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $2.14M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $11.61M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $17.38M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$1.47M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $4.76M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $4.76M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $6.05M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $8.29M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $9.81M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $15.98M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $23.08M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $19.9M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $27.19M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$6.41 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$1,581.81 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$6.41 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$1,581.81 |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $3.92M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $3.63M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$6.7M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$6.41M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$6.84M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$6.48M |